Pharmacology of COVID-19.

Sureda, Antoni; Habtemariam, Solomon; Nabavi, Seyed M

Sureda, Antoni; Habtemariam, Solomon; Nabavi, Seyed M.

Afiliação

Sureda A; Research Group in Community Nutrition and Oxidative Stress and Health Research Institute of the Balearic Islands (IdISBa), University of Balearic Islands-IUNICS, Palma de Mallorca, Spain; CIBEROBN (Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: antoni.sureda@uib.es.
Habtemariam S; Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Central Avenue, Charham-Maritime, Kent, ME4 4TB, UK.
Nabavi SM; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Chem Biol Interact ; 362: 110005, 2022 08 01.

Article em En | MEDLINE | ID: mdl-35662545

Assuntos

Tratamento Farmacológico da COVID-19; Antivirais/farmacologia; Antivirais/uso terapêutico; Humanos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google